Response to: 'Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?' by Liu et al
- PMID: 31097418
- DOI: 10.1136/annrheumdis-2019-215540
Response to: 'Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?' by Liu et al
Keywords: disease activity; systemic lupus erythematosus; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.Ann Rheum Dis. 2018 Oct;77(10):1507-1515. doi: 10.1136/annrheumdis-2018-212988. Epub 2018 Jun 26. Ann Rheum Dis. 2018. PMID: 29945921 Free PMC article.
-
Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?Ann Rheum Dis. 2020 Jun;79(6):e73. doi: 10.1136/annrheumdis-2019-215505. Epub 2019 Apr 20. Ann Rheum Dis. 2020. PMID: 31005899 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
